How are psychedelic drugs being used to treat mental illness and why is Australia a world leader in this space?
Psychedelic drugs, like psilocybin and MDMA, have captivated global interest for their potential in treating mental health disorders. While Australia has become the first country in the world to permit the prescription of these drugs, their efficacy is unconfirmed and access to these potentially transformative treatments is limited.
Dr Dilara Bahceci is a neuroscientist who specialises in the therapeutic potential of these psychoactive drugs. In this bitesize episode of the Scan, Dilara emphasises the pressing need to innovate mental health treatments and champions equitable access. Tune in to explore the evolving research landscape and exciting prospects ahead.
The Scan podcast from The George Institute for Global Health explores the latest research, emerging evidence, and crucial progress towards developing practical approaches towards better treatments, better care and healthier societies globally.